Detalhe da pesquisa
1.
The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors.
Allergy
; 78(11): 2980-2993, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452515
2.
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
BMC Med
; 20(1): 112, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35331214
3.
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer.
Prostate
; 81(13): 992-1001, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254334
4.
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.
JCO Clin Cancer Inform
; 7: e2300057, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490642
5.
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.
EBioMedicine
; 95: 104738, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549632
6.
AlphaBet: Combination of Radium-223 and [17 7Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol).
Front Med (Lausanne)
; 9: 1059122, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36465905
7.
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.
Eur Urol
; 81(3): 253-262, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493414
8.
Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
Front Immunol
; 12: 653710, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912179
9.
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer.
Eur Urol Focus
; 7(6): 1287-1291, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32739405
10.
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer.
Eur Urol Focus
; 7(1): 63-70, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31103601
11.
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250422
12.
Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer.
Transl Androl Urol
; 10(4): 1688-1699, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33968657
13.
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
EBioMedicine
; 72: 103625, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656931
14.
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.
Biotechniques
; 69(2): 133-140, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654508
15.
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
EBioMedicine
; 54: 102728, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268276
16.
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Eur Urol
; 78(2): 173-180, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487321
17.
Cell-free DNA in cancer: current insights.
Cell Oncol (Dordr)
; 42(1): 13-28, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367445
18.
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 73(6): 818-821, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398263